Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.1.3.16 (
calcineurin
)
17,112
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
TIMAP is a prenylated endothelial cell protein with a domain structure that predicts it to be a
protein phosphatase-1
(PP-1) regulatory subunit. We found that TIMAP interacts with the 37/67 kDa laminin receptor (
LAMR1
) in yeast two-hybrid assays. In endothelial cells, endogenous TIMAP and
LAMR1
co-immunoprecipitated and co-localized at the plasma membrane. TIMAP amino acids 261-290, representing the fourth ankyrin repeat of TIMAP, are necessary and sufficient for the interaction. In MDCK cells, lacking endogenous TIMAP, overexpression of full-length TIMAP, but not TIMAP deleted in the fourth ankyrin domain, allowed co-immunoprecipitation with
LAMR1
. PP-1 co-precipitated with overexpressed and endogenous TIMAP in MDCK and endothelial cells, respectively. In MDCK cells, PP-1 associated with
LAMR1
in the presence, but not in the absence, of TIMAP.
LAMR1
was a substrate for PP-1 in vitro, and in MDCK cells its phosphorylation was abrogated by expression of full-length TIMAP but not by TIMAP deficient in the fourth ankyrin domain. Hence, TIMAP targets PP-1 to
LAMR1
, and
LAMR1
is a TIMAP-dependent PP-1 substrate.
...
PMID:The protein phosphatase-1 targeting subunit TIMAP regulates LAMR1 phosphorylation. 1626 87